Skip to Content

Neo-Fradin Side Effects

Generic Name: neomycin

Note: This document contains side effect information about neomycin. Some of the dosage forms listed on this page may not apply to the brand name Neo-Fradin.

For the Consumer

Applies to neomycin: oral solution, oral tablet

Along with its needed effects, neomycin (the active ingredient contained in Neo-Fradin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking neomycin:

Rare

  • Any loss of hearing
  • clumsiness
  • diarrhea
  • difficulty in breathing
  • dizziness
  • drowsiness
  • greatly decreased frequency of urination or amount of urine
  • increased amount of gas
  • increased thirst
  • light-colored, frothy, fatty-appearing stools
  • ringing or buzzing or a feeling of fullness in the ears
  • skin rash
  • unsteadiness
  • weakness

Some side effects of neomycin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More Common

  • Irritation or soreness of the mouth or rectal area
  • nausea or vomiting

For Healthcare Professionals

Applies to neomycin: compounding powder, oral solution, oral tablet

General

The most commonly reported side effects included diarrhea, nausea, and vomiting.[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, nausea, vomiting

Frequency not reported: Increased fecal fat, increased salivation, steatorrhea, stomatitis[Ref]

Metabolic

Metabolic syndrome occurred with prolonged therapy, and included increased fecal fat, steatorrhea, decreased serum carotene, and a fall in xylose absorption. Steatorrhea and diarrhea occurring during metabolic syndrome can be very severe.[Ref]

Frequency not reported: Decreased serum carotene, electrolyte disturbances, fall in xylose absorption, hypocalcemia, hypokalemia, hypomagnesemia, malabsorption syndrome[Ref]

Nervous system

Frequency not reported: Neuromuscular blockade/blockage, neurotoxicity, nystagmus, paresthesia, vestibular toxicity[Ref]

Other

Frequency not reported: Drug fever, ototoxicity, permanent bilateral ototoxicity[Ref]

Hypersensitivity

Frequency not reported: Anaphylaxis, cross-sensitivity, hypersensitivity reactions[Ref]

Hepatic

Frequency not reported: Increased bilirubin levels, increased hepatic enzyme levels[Ref]

Hematologic

Frequency not reported: Blood dyscrasias, hemolytic anemia[Ref]

Psychiatric

Frequency not reported: Confusion, disorientation[Ref]

Dermatologic

Frequency not reported: Dermatitis, pruritus[Ref]

Renal

Frequency not reported: Nephrotoxicity[Ref]

Immunologic

Superinfection occurred with prolonged therapy.[Ref]

Frequency not reported: Superinfection[Ref]

Respiratory

Frequency not reported: Respiratory paralysis[Ref]

References

1. "Product Information. Mycifradin (neomycin)." Emerson Laboratories, Texarkana, TX.

2. "Product Information. Neomycin (neomycin)" Pharma-Tek, Huntington, NY.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide